Summary
Onorach Ltd (Onorach) is a contract research organization (CRO) which provides clinical trial support services. Its service portfolio includes tailored clinical trial support, clinical plan development, protocol design, regulatory, quality management, clinical operations management, patient and subject recruitment, project management, clinical monitoring, statistical analysis and medical report writing services among others. Onorach also provides temperature monitoring, stability testing, drug supplying, placebo sourcing, labeling, packaging, distribution, and pre-clinical and specialized lipid analysis services. The company’s target therapy areas include cardiovascular, cell based therapeutics, CNS, neurology, endocrinology, infectious diseases, oncology, pediatricians, women's health, and other therapeutics areas. It caters to pharmaceutical, biotech and medical device companies. Onorach is headquartered in Dundee, the UK.
Onorach Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Onorach Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
Onorach Ltd, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 7
Onorach Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
Onorach Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 9
Onorach Ltd, Medical Devices Deals, 2010 to YTD 2016 10
Onorach Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11
Onorach Ltd, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Epirus Biopharma Raises US$36 Million In Series B Venture Financing 13
Private Equity 15
BioGeneration Ventures, Thuja Capital and Forbion Capital Partners Divest Bioceros 15
Partnerships 16
Polpharma Enters into Agreement with Epirus Biopharma 16
EPIRUS Biopharma Enters into Distribution Agreement with mAbxience 17
Epirus Biopharma Enters into Co-Development Agreement with Livzon Mabpharm 18
Epirus Enters Into Co-Development Agreement With Orygen Biotecnologia 19
Zalicus And Hydra Biosciences Enter Into Partnership To Develop Ion Channel Product Candidates For Treatment Of Pain 20
Licensing Agreements 22
Zalicus Enters into Licensing Agreement with AnaBios for Sodium Channel Pain Modulation Program 22
Epirus Enters Into Licensing Agreement With Ranbaxy Labs For BOW015 23
Zalicus Extends Licensing Agreement With Novartis Institutes For Oncology Combinations 24
Bioceros Expands Licensing Agreement With Crucell 25
Zalicus Extends Licensing Agreement With Novartis Institutes for BioMedical Research 26
Oncomab Enters Into Licensing Agreement With Bioceros 27
Equity Offering 28
Epirus Biopharma to Raise up to USD30 Million in Public Offering of Shares 28
Epirus Biopharma Raises USD53 Million in Public Offering of Shares 30
Zalicus Completes First Tranche Of Private Placement Of Shares For US$2 Million 32
Zalicus Completes Public Offering Of Shares For US$15 Million 34
Zalicus Completes Second Tranche Of Private Placement Of Shares For US$9 Million 35
Zalicus Completes Second Tranche Of Private Placement Of Shares For US$4.25 Million 36
Asset Transactions 37
Horizon Discovery Completes Acquisition of Combination High Throughput Screening from Zalicus 37
Acquisition 39
Polpharma to Acquire EPIRUS Netherlands from EPIRUS Biopharma 39
Taro Pharma Acquires Zalicus Pharma 41
Epirus Biopharma Acquires Bioceros for USD14 Million 42
Epirus Biopharma Acquires Zalicus in Reverse Takeover Transaction 44
Onorach Ltd - Key Competitors 46
Key Employees 47
Locations And Subsidiaries 48
Head Office 48
Other Locations & Subsidiaries 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49
List of Tables
Onorach Ltd, Pharmaceuticals & Healthcare, Key Facts 1
Onorach Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
Onorach Ltd, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 7
Onorach Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
Onorach Ltd, Deals By Therapy Area, 2010 to YTD 2016 9
Onorach Ltd, Medical Devices Deals, 2010 to YTD 2016 10
Onorach Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11
Epirus Biopharma Raises US$36 Million In Series B Venture Financing 13
BioGeneration Ventures, Thuja Capital and Forbion Capital Partners Divest Bioceros 15
Polpharma Enters into Agreement with Epirus Biopharma 16
EPIRUS Biopharma Enters into Distribution Agreement with mAbxience 17
Epirus Biopharma Enters into Co-Development Agreement with Livzon Mabpharm 18
Epirus Enters Into Co-Development Agreement With Orygen Biotecnologia 19
Zalicus And Hydra Biosciences Enter Into Partnership To Develop Ion Channel Product Candidates For Treatment Of Pain 20
Zalicus Enters into Licensing Agreement with AnaBios for Sodium Channel Pain Modulation Program 22
Epirus Enters Into Licensing Agreement With Ranbaxy Labs For BOW015 23
Zalicus Extends Licensing Agreement With Novartis Institutes For Oncology Combinations 24
Bioceros Expands Licensing Agreement With Crucell 25
Zalicus Extends Licensing Agreement With Novartis Institutes for BioMedical Research 26
Oncomab Enters Into Licensing Agreement With Bioceros 27
Epirus Biopharma to Raise up to USD30 Million in Public Offering of Shares 28
Epirus Biopharma Raises USD53 Million in Public Offering of Shares 30
Zalicus Completes First Tranche Of Private Placement Of Shares For US$2 Million 32
Zalicus Completes Public Offering Of Shares For US$15 Million 34
Zalicus Completes Second Tranche Of Private Placement Of Shares For US$9 Million 35
Zalicus Completes Second Tranche Of Private Placement Of Shares For US$4.25 Million 36
Horizon Discovery Completes Acquisition of Combination High Throughput Screening from Zalicus 37
Polpharma to Acquire EPIRUS Netherlands from EPIRUS Biopharma 39
Taro Pharma Acquires Zalicus Pharma 41
Epirus Biopharma Acquires Bioceros for USD14 Million 42
Epirus Biopharma Acquires Zalicus in Reverse Takeover Transaction 44
Onorach Ltd, Key Competitors 46
Onorach Ltd, Key Employees 47
Onorach Ltd, Subsidiaries 48
List of Figures
Onorach Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Onorach Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Onorach Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Onorach Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Onorach Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
Onorach Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 7
Onorach Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
Onorach Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 9
Onorach Ltd, Medical Devices Deals, 2010 to YTD 2016 10
